Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.33Price to Book
VS
Market
Sector
Industry
History
$ 2.7Close
$ 1.41 - $ 4 52-Week Range
Ticker Information
Ticker
FBIOCompany Name
FORTRESS BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQFORTRESS BIOTECH INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FBIO - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 43.92M | $ 58.32M | 1.33 |
| 3/31/2025 | $ 22.25M | $ 52.63M | 2.37 |
| 12/31/2024 | $ 22.74M | $ 46.07M | 2.03 |
| 9/30/2024 | $ 21.16M | $ 43.34M | 2.05 |
| 6/30/2024 | $ 17.88M | $ 41.75M | 2.34 |
| 3/31/2024 | $ 23.02M | $ 34.65M | 1.51 |
| 12/31/2023 | $ 22.54M | $ 38.47M | 1.71 |
| 9/30/2023 | $ 16.67M | $ 11.8M | 0.71 |
| 6/30/2023 | $ 18.51M | $ 71.44M | 3.86 |
| 3/31/2023 | $ 37.8M | $ 94.97M | 2.51 |
Key Performance Insights, Last 5 Years
- FORTRESS BIOTECH INC's latest trailing twelve months (TTM) P/B stands at 2.26.
- Over the past 5 years, FORTRESS BIOTECH INC's average P/B has been 2.18.
- The median P/B for FORTRESS BIOTECH INC during this period was 2.15
- FORTRESS BIOTECH INC reached its highest P/B over the past 5 years at 3.86.
- The lowest P/B recorded by FORTRESS BIOTECH INC in the same timeframe 0.71
FORTRESS BIOTECH INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for FORTRESS BIOTECH INC is calculated as follows: Market Cap [ $ 219.26M ] / Equity [ $ 97.11M ]
(=) P/B [ 2.26 ] FBIO - Price to Book, Last 5 years
0.71
Minimum
Sep 30, 2023
3.86
Maximum
Jun 30, 2023
2.18
Average
2.15
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |